"Valve replacement" from_date:2012

Endovascular implantation of a transcatheter tricuspid valve replacement for tricuspid valve insufficiency ' assessment according to '137h Social Code Book (SGB) V 1 Translation of the executive summary of the §137h assessment H23-03 Endovaskuläre Implantation eines Transkatheter-Trikuspidalklappenersatzes bei Trikuspidalklappeninsuffizienz (Version 1.0; Status: 8 May 2024). Please note : This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. Endovascular implantation of a transcatheter tricuspid valve replacement for tricuspid valve insufficiency1 EXTRACT DOI: 10.60584/H23-03_en 1.0 Version: H23-03 Project: Extract of §137h assessment H23-03 Version 1.0 Endovascular tricuspid valve

Limited versus full sternotomy for aortic valve replacement. Aortic valve disease is a common condition easily treatable with cardiac surgery. This is conventionally performed by opening the sternum ('median sternotomy') and replacing the valve under cardiopulmonary bypass. Median sternotomy is well tolerated, but as less invasive options become available, the efficacy of limited incisions has decreased pain; improved respiratory mechanics; reductions in wound infections, bleeding, and need for transfusion; shorter intensive care stay; better cosmesis; and a quicker return to normal activity. This is an update of a Cochrane review first published in 2017, with seven new studies. To assess the effects of minimally invasive aortic valve replacement via a limited sternotomy versus conventional

SCAI Expert Consensus Statement on Alternative Access for Transcatheter Aortic Valve Replacement www.jscai.org Verify you are human by completing the action below. www.jscai.org needs to review the security of your connection before proceeding.Ray ID: 921cb278f9f64130Performance & security by Cloudflare

Transcatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR) for symptomatic, severe aortic stenosis (adults) to support elective performance Skip to main contentCreating a new NHS England: NHS Digital and NHS England have now merged. Health Education England will join us in April 2023. Learn more.Home News Publications Statistics Blogs Events Contact usSearch SearchAbout us Our work Commissioning Get involved CoronavirusTranscatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR) for symptomatic, severe aortic stenosis (adults) to support elective performanceDocument first published:1 February 2023Page updated:2 February 2023Topic:Heart disease, Specialised commissioningPublication type:Policy or strategyNHS England (NHSE) has

Preprocedural Planning for Transcatheter Aortic Valve Replacement Revised 2023 ACR Appropriateness Criteria® 1 Transcatheter Aortic Valve Replacement American College of Radiology ACR Appropriateness Criteria®Preprocedural Planning for Transcatheter Aortic Valve Replacement Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial contrast Usually Not Appropriate O CT chest with IV contrast Usually Not Appropriate ☢☢☢CT chest without and with IV contrast Usually Not Appropriate ☢☢☢CT chest without IV contrast Usually Not Appropriate ☢☢☢ACR Appropriateness Criteria® 2 Transcatheter Aortic Valve Replacement Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular

Preprocedural Planning for Transcatheter Aortic Valve Replacement Revised 2023 ACR Appropriateness Criteria® 1 Transcatheter Aortic Valve Replacement American College of Radiology ACR Appropriateness Criteria®Preprocedural Planning for Transcatheter Aortic Valve Replacement Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial contrast Usually Not Appropriate O CT chest with IV contrast Usually Not Appropriate ☢☢☢CT chest without and with IV contrast Usually Not Appropriate ☢☢☢CT chest without IV contrast Usually Not Appropriate ☢☢☢ACR Appropriateness Criteria® 2 Transcatheter Aortic Valve Replacement Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular

Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups: a health technology assessment Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups Get alerts of updates about «Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups»How often would you like to receive alerts from fhi.no? (This affects all

Redo Surgical Aortic Valve Replacement versus Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprosthetic Valves. Valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) is associated with improved perioperative safety compared to redo surgical aortic valve replacement (redo-SAVR), but long-term outcomes remain uncertain. We therefore compare long-term outcomes

Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter Versus Surgical Aortic Valve Replacement with Concomitant Valve Disease. The etiology of increased risk for reoperation after transcatheter aortic valve replacement (TAVR) versus prior surgical aortic valve replacement (SAVR) is poorly understood. This study evaluated the impact of concomitant mitral and tricuspid valve disease on associated risk of TAVR explant. Patients undergoing aortic valve replacement after prior SAVR or TAVR were extracted from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (2011-2021). Patients were stratified by TAVR explant status and presence of severe concomitant valve disease for analyses. Risk adjustment was performed using multivariable logistic regression

Infective endocarditis after isolated aortic valve replacement: comparison between catheter-interventional and surgical valve replacement. Prosthetic valve endocarditis (PVE) is the prognostically most unfavourable complication after aortic valve replacement. This study aims to contribute to a better understanding of the different pathological and therapeutical aspects between PVE following surgical (SAVR) and transcatheter aortic valve replacement (TAVI). All patients who had undergone primary isolated SAVR (n = 3447) or TAVI (n = 2269) at our Centre between 01/2012 and 12/2018 were analysed. Diagnosis of PVE was based on Duke criteria modified in 2015. Incidence, risk factors, pathogens, impact of complications or therapy on mortality were analysed and compared between SAVR- and TAVI-PVE

Robotic Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement: A Propensity Matched Analysis. Current evidence supports equipoise between surgical valve replacement and TAVR for the management of symptomatic severe aortic stenosis (AS). For patients of lower risk, controversy exists regarding the optimal interventional management. Minimally invasive robotic aortic valve replacement (RAVR) was developed as a potential option. A total of 605 consecutive patients (2017-2023) managed by the identical structural heart team, 174 RAVR and 431 TAVR, were propensity matched and evaluated for in-hospital and one-year outcomes. There were 288 low-intermediate risk (STS PROM <8%) patients matched in two well-balanced groups (144 RAVR vs 144 TAVR). In-hospital and 30-day mortality were

Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis-We Need a Well-Designed Randomized Control Trial. Bicuspid aortic stenosis is a common pathology, typically seen in patients a decade younger than those with tricuspid valves. Surgical aortic valve replacement has been the mainstay treatment for bicuspid disease, especially considering the prevalence of concomitant aortic aneurysmal pathology. Transcatheter aortic valve replacement has shown equivalent results in bicuspid compared to tricuspid pathology in highly selected patient populations in single-arm registries and observational studies. For older patients with favorable bicuspid pathology, TAVR is reasonable. However, as younger patients with longer life expectancy

Contribution margins and utilization of transcatheter aortic valve replacement versus surgical aortic valve replacement in the Medicare population. Hospitals and health systems must balance the demand for transcatheter aortic valve replacement (TAVR) against financial sustainability. Patients may be eligible for both TAVR and surgical aortic valve replacement (SAVR), but financial realities

Sutureless aortic valve replacement for aortic stenosis Sutureless aortic valve replacement for aortic stenosis Interventional procedures guidance Published: 22 August 2018 www.nice.org.uk/guidance/ipg624 Your responsibility Your responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare and reduce the environmental impact of implementing NICE recommendations wherever possible. This guidance replaces IPG456. © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights).Page 1 of51 1 Recommendations Recommendations 1.1 Current evidence on the safety and efficacy of sutureless aortic valve replacement for aortic stenosis

Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement Compared With Surgical Valve Replacement in Intermediate-Risk Patients. Previous studies demonstrated transcatheter aortic valve replacement (TAVR) with an earlier generation balloon-expandable valve to be noninferior to surgical aortic valve replacement (SAVR) for death and disabling stroke in intermediate-risk patients

Valve-in-valve Transcatheter Aortic Valve Replacement versus isolated redo Surgical Aortic Valve Replacement. To compare outcomes of patients undergoing valve-in-valve transcatheter aortic valve replacement (ViV TAVR) versus redo surgical aortic valve replacement (SAVR). This was a retrospective study using institutional databases of transcatheter (2013-2022) and surgical (2011-2022) aortic valve replacements. Patients who underwent ViV TAVR were compared to patients who underwent redo isolated SAVR. Clinical and echocardiographic outcomes were analyzed. Kaplan-Meier survival estimation and Cox regression were performed. Cumulative incidence functions were generated for heart failure readmissions. A total of 4,200 TAVRs and 2,306 isolated SAVRs were performed. Of these, there were 198

Effect of leaflet laceration on transcatheter aortic valve replacement fluid mechanics and comparison with surgical aortic valve replacement. Leaflet thrombosis after surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) may be caused by blood flow stagnation in the native and neosinus regions. To date, aortic leaflet laceration has been used to mitigate

Comparison of Postdischarge Outcomes Between Valve-in-Valve Transcatheter Mitral Valve Replacement and Reoperative Surgical Mitral Valve Replacement. Limited data are available comparing the postdischarge perioperative outcomes of isolated valve-in-valve transcatheter mitral valve replacement (VIV-TMVR) versus surgical reoperative mitral valve replacement (re-SMVR) on a nationwide scale

Redefining "low risk": Outcomes of surgical aortic valve replacement in low-risk patients in the transcatheter aortic valve replacement era. Guidelines suggest aortic valve replacement (AVR) for low-risk asymptomatic patients. Indications for transcatheter AVR now include low-risk patients, making it imperative to understand state-of-the-art surgical AVR (SAVR) in this population. Therefore, we

In patients with severe aortic stenosis and low surgical risk, is transcatheter aortic valve replacement (TAVR) non-inferior to surgical aortic valve replacement (SAVR) in regards to death or disabling stroke? Evolut Low Risk - Wiki Journal ClubEvolut Low RiskFrom Wiki Journal ClubJump to navigationJump to searchPublishedPopma JJ, et al. "Transcatheter aortic-valve replacement with a self * 9 Criticisms * 10 Funding * 11 Further Reading Clinical QuestionIn patients with severe aortic stenosis and low surgical risk, is transcatheter aortic valve replacement (TAVR) non-inferior to surgical aortic valve replacement (SAVR) in regards to death or disabling stroke? Bottom LineAmong patients with severe AS and low surgical risk, TAVR was found to be non-inferior to SAVR in regards